Intelligenome Announces R&D Subaward Agreement with Cornell University
Intelligenome, a global leader in CRISPR-based in vitro diagnostic (IVD) technology, is pleased to announce that it has entered into a research and development subaward agreement with Cornell University to support the development of a rapid, low-cost, portable diagnostic solution for tuberculosis (…
Intelligenome, a global leader in CRISPR-based in vitro diagnostic (IVD) technology, is pleased to announce that it has entered into a research and development subaward agreement with Cornell University to support the development of a rapid, low-cost, portable diagnostic solution for tuberculosis (TB).